IP Library Granted Patent US 6,939,669
Granted Patent B2
US 6,939,669 · App. 10/071,039 · Granted Sep 6, 2005

Expansion of hematopoietic cells using midkine or pleiotrophin

Assignee: Meiji Dairies Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,939,669
App. No.
10/071,039
Granted
Sep 6, 2005
Kind
B2
Abstract

The present invention provides novel use of the MK family that is used alone as an agent for proliferating hematopoietic stem cells and hematopoietic precursor cells. The invention also provides an agent for remarkably enhancing the above-described effect for promoting the proliferation of hematopoietic stem cells and hematopoietic precursor cells, comprising the MK family in combination with known hematopoietic factors such as IL-3, IL-6, G-CSF, GM-CSF, M-CSF, SCF, and EPO.

Claims (8)

1. A method for promoting ex vivo expansion of hematopoietic stem cells or hematopoietic progenitor cells, said method comprising culturing hematopoietic stem cells or hematopoietic progenitor cells with a composition comprising: (a) purified midkine (MK) protein or purified pleiotrophin (PTN) protein; and (b) one or more other purified hematopoietic growth factors selected from the group consisting of interleukin-3 (IL-3), interleukin-6 (IL-6), granulocyte colony stimulating-factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), stem cell factor (SCF), and erythropoietin (EPO).

2. A method for promoting ex vivo expansion of hematopoietic stem cells or hematopoietic progenitor cells, said method comprising culturing hematopoietic stem cells or hematopoietic progenitor cells with a composition comprising: (a) purified midkine (MK) protein; and (b) one or more other purified hematopoietic growth factors selected from the group consisting of interleukin-3 (IL-3), interleukin-6 (IL-6), granulocyte colony stimulating-factor (G-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), stem cell factor (SCF), and erythropoietin (EPO).

3. The method of claim 1 , wherein the hematopoietic stem cells or hematopoietic progenitor cells are obtained from bone narrow, peripheral blood, or umbilical cord blood.

4. The method of claim 1 , wherein the hematopoietic stem cells are colony-forming units-mix (CFU-mix).

5. The method of claim 1 , wherein the other purified hematopoietic growth factors are IL-3, IL-6, SCF, and EPO.

6. The method of claim 2 , wherein the hematopoietic stem cells or hematopoietic progenitor cells are obtained from bone marrow, peripheral blood, or umbilical cord blood.

7. The method of claim 2 , wherein the hematopoietic stem cells are colony-farming units-mix (CFU-mix).

8. The method of claim 2 , wherein the other purified hematopoietic growth factors are IL-3, IL-6, SCF, and EPO.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2013
From: MURAMATSU, TAKASHI
To: MEDICAL THERAPIES LIMITED
Reel/Frame 029919/0785 →
CHANGE OF NAME Recorded Mar 1, 2013
From: MEDICAL THERAPIES LIMITED
To: CELLMID LIMITED
Reel/Frame 029919/0800 →
CORRECTIVE ASSIGNMENT TO CORRECT ASSIGNEE'S ADDRESS PREVIOUSLY RECORDED AT REEL: 016835, FRAME: 0084 Recorded Mar 9, 2006
From: MEIJI DAIRIES CORPORATION
To: MURAMATSU, TAKASHI
Reel/Frame 017320/0802 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2005
From: MEIJI DAIRIES CORPORATION
To: MURAMATSU, TAKASHI
Reel/Frame 016835/0084 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2005
From: KIKUCHI, MAKOTO; IKEMATSU, SHINYA; ODA, MUNEHIRO; SAKUMA, SADATOSHI; MURMATSU, TAKASHI
To: MEIJI DAIRIES CORPORATION
Reel/Frame 015819/0273 →
CHANGE OF NAME AND ADDRESS OF APPLICANT Recorded Jul 29, 2004
From: MEIJI MILK PRODUCTS CO., LTD
To: MEIJI DAIRIES CORPORATION
Reel/Frame 015612/0260 →
Priority Claims (1)
JP 8-198531 · Jul 10, 1996 · national
Continuity (2)
Division 0921456900
Related Publication 20020132984A1 · Sep 19, 2002